Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 1/20 | 0.33 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.33 |
| ▸ | CAMKK2 | Q96RR4 | 2/20 | 0.33 |
| ▸ | AVPR1B | P47901 | 1/20 | 0.33 |
| ▸ | CAMKK1 | Q8N5S9 | 1/20 | 0.33 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 7/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | ABHD12 | Q8N2K0 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5422240 | 0.90 | CD274 (0.36) | AGTR1AGTR2CAMKK2CAMKK1PPARG | |
| SCHEMBL5426457 | 0.90 | CAMKK1 (0.34) | AGTR1AGTR2CAMKK2CAMKK1LTB4R2 | |
| SCHEMBL12502388 | 0.90 | KMT2A (0.37) | AGTR1AGTR2CAMKK2CAMKK1LTB4R2 | |
| SCHEMBL1290163 | 0.90 | AGTR1 (0.35) | AGTR1AGTR2CAMKK2CAMKK1PPARG | |
| SCHEMBL5416290 | 0.90 | AVPR1B (0.40) | CAMKK2AVPR1BCAMKK1PIK3CAMTOR | |
| SCHEMBL22641572 | 0.90 | AGTR1 (0.32) | AGTR1AGTR2CAMKK2CAMKK1LTB4R2 | |
| SCHEMBL20960274 | 0.90 | PPARG (0.33) | AGTR1AGTR2CAMKK2CAMKK1PPARG | |
| SCHEMBL20083150 | 0.89 | S1PR1 (0.36) | AGTR1AGTR2CAMKK2CAMKK1PPARG | |
| SCHEMBL5426746 | 0.89 | KDM4E (0.39) | KDM4EALDH1A1GAA | |
| SCHEMBL1290213 | 0.88 | AGTR1 (0.34) | AGTR1AGTR2CAMKK2AVPR1BCAMKK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7223773-B2 | 4-oxoquinolizine antibacterial agent having 2-pyridone skeleton as partial structure | SALO PHARMACEUTICAL CO., LTD. (JP) | 2007-05-29 | — | — | US | disclosed |
| US-20040229903-A1 | 4-Oxoquinolizine antibacterial agent having 2-pyridone skeleton as partial structure | SATO PHARMACEUTICAL CO., LTD. (JP) | 2004-11-18 | — | — | US | disclosed |
| EP-1437354-A1 | 4-OXOQUINOLIZINE ANTIMICROBIALS HAVING 2-PYRIDONE SKELETON AS PARTIAL STRUCTURE | Sato Pharmaceutical Co. Ltd. (JP) | 2004-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229903-A1 | 4-Oxoquinolizine antibacterial agent having 2-pyridone skeleton as partial structure | SDHA, IL4I1, BLVRB | AGTR1 170/4885AGTR2 289/4885CAMKK2 2773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.